Researchers used Sangamo's ZFP technology to repress a specific gene variant, preventing fat cells from developing. This breakthrough demonstrates the precision of ZFPs in regulating gene expression and may lead to new treatments for diseases related to fat cell development.
Researchers have discovered that synthetic catalytic anti-oxidants can rescue a severe neurological phenotype and enhance lifespan of mice engineered to undergo oxidative damage. Treatment with these compounds resulted in a dramatic improvement in survival rate and reversal of neurodegenerative disorders.
Eukarion's antibody lipidation technology successfully blocks HIV-1 viral replication in human lymphocytic cells by targeting the Tat protein. The modified anti-Tat antibody is effective against laboratory and patient-strain viruses, offering new potential for cell-specific AIDS immunotherapies.